Advertisement

ECG-MRI based Localization of Myocardial Infarction

  • Henrik Engblom
  • Olle Pahlm
Conference paper

Abstract

Magnetic resonance imaging (MRI) has emerged in the last decade as an important method for characterizing various aspects of cardiac anatomy, patho-anatomy, pathophysiology, and function. Measurements of flow parameters, left ventricular function, and grade of valvular regurgitation have been validated and proved to serve as excellent gold standards compared to simpler, established techniques, such as echocardiography, thermodilution measurements, and electrocardiography [1].

Keywords

Myocardial Infarct Size Infarct Transmurality Chronic Ischemic Heart Disease Extracellular Contrast Agent Delay Enhancement Magnetic Resonance Imaging 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Bellenger NG, Davies LC, Francis JM et al (2000) Reduction in sample size for studies of remodeling in heart failure by the use of cardiovascular magnetic resonance. J Cardiovasc Magn Reson 2:271–278PubMedGoogle Scholar
  2. 2.
    Pennell DJ, Sechtem UP, Higgins CB et al (2004) Clinical indications for cardiovascular magnetic resonance (CMR): Consensus Panel report. Eur Heart J 25:1940–1965PubMedCrossRefGoogle Scholar
  3. 3.
    Choi KM, Kim RJ, Gubernikoff G et al (2001) Transmural extent of acute myocardial infarction predicts long-term improvement in contractile function. Circulation 104:1101–1107PubMedCrossRefGoogle Scholar
  4. 4.
    Engblom H, Hedstrom E, Heiberg E et al (2007) Time course and magnitude of infarct involution, functional recovery, and electrocardiographic changes in patients with reperfused first myocardial infarction. (submitted)Google Scholar
  5. 5.
    Kim RJ, Wu E, Rafael A et al (2000) The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med 343:1445–1453PubMedCrossRefGoogle Scholar
  6. 6.
    Tragardh E, Engblom H, Pahlm O (2006) How many ECG leads do we need? Cardiol Clin 24:317–330, viiPubMedCrossRefGoogle Scholar
  7. 7.
    Tong CY, Prato FS, Wisenberg G et al (1993) Measurement of the extraction efficiency and distribution volume for Gd-DTPA in normal and diseased canine myocardium. Magn Reson Med 30:337–346PubMedCrossRefGoogle Scholar
  8. 8.
    Arheden H, Saeed M, Higgins CB et al (1999) Measurement of the distribution volume of gadopentetate dimeglumine at echo-planar MR imaging to quantify myocardial infarction: comparison with 99mTc-DTPA autoradiography in rats. Radiology 211:698–708PubMedGoogle Scholar
  9. 9.
    Rehwald WG, Fieno DS, Chen EL et al (2002) Myocardial magnetic resonance imaging contrast agent concentrations after reversible and irreversible ischemic injury. Circulation 105:224–229PubMedCrossRefGoogle Scholar
  10. 10.
    Klein C, Nekolla SG, Balbach T et al (2004) The influence of myocardial blood flow and volume of distribution on late Gd-DTPA kinetics in ischemic heart failure. J Magn Reson Imaging 20:588–593PubMedCrossRefGoogle Scholar
  11. 11.
    Nishimura T, Yamada Y, Hayashi M et al (1989) Determination of infarct size of acute myocardial infarction in dogs by magnetic resonance imaging and gadolinium-DTPA: comparison with indium-111 antimyosin imaging. Am J Physiol Imaging 4:83–88PubMedGoogle Scholar
  12. 12.
    Kim RJ, Fieno DS, Parrish TB et al (1999) Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation 100:1992–2002PubMedGoogle Scholar
  13. 13.
    Heiberg E, Ugander M, Engblom H et al (2007) Accounting for partial volume effects in the automated quantification of myocardial infarction from delayed enhancement MRI. Radiology (in press)Google Scholar
  14. 14.
    Hsu LY, Natanzon A, Kellman P et al (2006) Quantitative myocardial infarction on delayed enhancement MRI. Part I: Animal validation of an automated feature analysis and combined thresholding infarct sizing algorithm. J Magn Reson Imaging 23:298–308PubMedCrossRefGoogle Scholar
  15. 15.
    Foster JE, Arheden H, Engblom H (2007) Myocardial infarct quantification: is MR imaging ready to serve as gold standard for ECG? J Electrocardiol (in press)Google Scholar
  16. 16.
    Moon JC, De Arenaza DP, Elkington AG et al (2004) The pathologic basis of Q wave and non-Q wave myocardial infarction: a cardiovascular magnetic resonance study. J Am Coll Cardiol 44:554–560PubMedCrossRefGoogle Scholar
  17. 17.
    Kaandorp TA, Bax JJ, Lamb HJ et al (2005) Which parameters on magnetic resonance imaging determine Q waves on the electrocardiogram? Am J Cardiol 95:925–929PubMedCrossRefGoogle Scholar
  18. 18.
    Engblom H, Hedstrom E, Heiberg E et al (2005) Size and transmural extent of first-time reperfused myocardial infarction assessed by cardiac magnetic resonance can be estimated by 12-lead electrocardiogram. Am Heart J 150:920PubMedGoogle Scholar
  19. 19.
    Engblom H, Carlsson MB, Hedström E et al (2007) The endocardial extent of reperfused myocardial infarction is a stronger determinant of pathological Q waves than is infarct transmurality. Clin Physiol Funct Imag 27:101–108CrossRefGoogle Scholar
  20. 20.
    Bayes de Luna A, Wagner G, Birnbaum Y et al (2006) A new terminology for left ventricular walls and location of myocardial infarcts that present Q wave based on the standard of cardiac magnetic resonance imaging: a statement for healthcare professionals from a committee appointed by the International Society for Holter and Noninvasive Electrocardiography. Circulation 114:1755–1760PubMedCrossRefGoogle Scholar
  21. 21.
    Cerqueira MD, Weissman NJ, Dilsizian V et al (2002) Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: a statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation 105:539–542PubMedCrossRefGoogle Scholar
  22. 22.
    Durrer D, van Dam RT, Freud GE et al (1970) Total excitation of the isolated human heart. Circulation 41:899–912PubMedGoogle Scholar
  23. 23.
    Ideker RE, Wagner GS, Ruth WK et al (1982) Evaluation of a QRS scoring system for estimating myocardial infarct size. II. Correlation with quantitative anatomic findings for anterior infarcts. Am J Cardiol 49:1604–1614PubMedCrossRefGoogle Scholar
  24. 24.
    Roark SF, Ideker RE, Wagner GS et al (1983) Evaluation of a QRS scoring system for estimating myocardial infarct size. III. Correlation with quantitative anatomic findings for inferior infarcts. Am J Cardiol 51:382–389PubMedCrossRefGoogle Scholar
  25. 25.
    Ward RM, White RD, Ideker RE et al (1984) Evaluation of a QRS scoring system for estimating myocardial infarct size. IV. Correlation with quantitative anatomic findings for posterolateral infarcts. Am J Cardiol 53:706–714PubMedCrossRefGoogle Scholar
  26. 26.
    Engblom H, Wagner GS, Setser RM et al (2003) Quantitative clinical assessment of chronic anterior myocardial infarction with delayed enhancement magnetic resonance imaging and QRS scoring. Am Heart J 146:359–366PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Italia 2007

Authors and Affiliations

  • Henrik Engblom
    • 1
  • Olle Pahlm
    • 1
  1. 1.Department of Clinical PhysiologyUniversity HospitalLundSweden

Personalised recommendations